| Israele | Turchia | Austria | |
| Medication treatment for multiple sclerosis | - | da $2,500 | da $2,000 |
| Ocrevus (ocrelizumab) | - | da $10,000 | da $35,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Trattamento farmacologico per la sclerosi multipla. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Trattamento farmacologico per la sclerosi multipla al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Trattamento farmacologico per la sclerosi multipla e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Trattamento farmacologico per la sclerosi multipla.
Giorno 1
Giorno 2
Giorno 3
Dal Giorno 4 al Giorno 14
Settimana 3
Settimana 4
Settimana 5
Nota: Il percorso di ogni paziente con la sclerosi multipla è differente. Questo piano è una linea guida generale e può essere adattato in base alle esigenze individuali.
Dr. Dimitrios Karussis is a neurologist with 30 years of experience. He specializes in neuroimmunology and bone marrow transplantation. He leads the EAE Laboratory and the Multiple Sclerosis Clinic at Hadassah Medical Center in Jerusalem.
Dr. Karussis is board-certified in neurology in Greece, the European Union, and Israel. He is a member of the European Steering Committee for Bone Marrow Transplantation in multiple sclerosis. He also serves on the executive boards of major neuroimmunology societies. Dr. Karussis has published over 200 scientific papers and reviews articles for international journals.
Dr. Eduard Linecki is a neurologist at Hadassah Medical Center with more than 23 years of clinical experience. He focuses on neurology, polyneuropathy, and neurooncology. He has strong expertise in managing and treating Parkinson's disease.
Dr. Linecki earned his medical degree in 1996. He completed his internship at Hadassah in 2001. He is known for achieving good results in Parkinson's disease therapy. He is also skilled in treating complex nervous system disorders.
Professor Tamir Ben-Hur is a neurologist specializing in stem cell therapy for neurological disorders, regenerative medicine, and neuroimmunology. He has a degree in general medicine from the Hebrew University Hadassah Medical School and a specialty in neurology from Hadassah University Hospital. He is the Director of the Clinical Neurosciences Division at the Hadassah University Hospital at Ein Kerem and has written over 100 papers. He is a member of several organizations, including the Israel Neurological Association, the American Neurological Association, the International Society of Neuroimmunology, the American Academy of Neurology, and the Society for Neuroscience.